Approved new vaccine for Respiratory Syncytial Virus (RSV)
The European Commission has approved 'Beyfortus' (nirsevimab) for the prevention of lower respiratory tract infection caused by respiratory syncytial virus (RSV) in newborns and infants during their first RSV season. RSV is a common and highly contagious seasonal...